MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 05.11.2025
TG Therapeutics P/B 2011-2026 | TGTX
P/B Jährlich TG Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.1 | 15.1 | 34.9 | 6.45 | 10.7 | 32.6 | 13.6 | 10.8 | 6.43 | 3.67 | 6.06 | 3.9 | 3.08 | 0.203 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 34.9 | 0.203 | 12.1 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M |  USA |
 |
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M |  Germany |
 |
Adaptimmune Therapeutics plc
ADAP
|
51.9 | - | -15.15 % | $ 60.3 M |  Britain |
 |
Adverum Biotechnologies
ADVM
|
1.08 | - | - | $ 86.2 M | USA |
 |
Amarin Corporation plc
AMRN
|
0.797 | $ 14.85 | 0.68 % | $ 6.05 B |  Irlanda |
 |
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M |  Canada |
 |
I-Mab
IMAB
|
1.12 | - | - | $ 866 M |  China |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | USA |
 |
Aptorum Group Limited
APM
|
0.347 | $ 0.86 | 2.86 % | $ 4.69 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Adagene
ADAG
|
1.74 | $ 2.9 | 8.61 % | $ 163 M | China |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M |  France |
 |
AlloVir
ALVR
|
0.432 | - | 4.14 % | $ 49.1 M | USA |
 |
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | USA |
 |
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.57 | - | $ 8.59 B |  Australia |
 |
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | USA |
 |
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | USA |
 |
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | USA |
 |
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | Canada |
 |
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
8.34 | $ 221.04 | -0.45 % | $ 5 B |  Danmark |
 |
Allena Pharmaceuticals
ALNA
|
3.16 | - | 3.16 % | $ 1.9 M | USA |
 |
Aptinyx
APTX
|
0.248 | - | -39.0 % | $ 4.57 M | USA |
 |
Aravive
ARAV
|
5.67 | - | -13.39 % | $ 1.45 M | USA |
 |
BioNTech SE
BNTX
|
5.29 | $ 112.26 | 1.74 % | $ 27.2 B | Germany |
 |
Cabaletta Bio
CABA
|
0.0867 | $ 2.63 | 7.58 % | $ 3.07 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
7.2 | - | -6.81 % | $ 3.04 B | USA |
 |
Aridis Pharmaceuticals
ARDS
|
-0.17 | - | 17.91 % | $ 11.1 M | USA |
 |
Burford Capital Limited
BUR
|
1.26 | $ 9.24 | 2.95 % | $ 1.48 B | Britain |
 |
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | USA |
 |
Athira Pharma
ATHA
|
0.36 | - | - | $ 269 M | USA |
 |
Athersys
ATHX
|
11.6 | - | 3.77 % | $ 22.4 M | USA |
 |
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | USA |
 |
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 4.61 | 7.59 % | $ 10 B |  Israel |
 |
Autolus Therapeutics plc
AUTL
|
0.991 | $ 1.47 | 0.79 % | $ 375 M | Britain |
 |
Amneal Pharmaceuticals
AMRX
|
0.522 | $ 14.61 | 0.59 % | $ 4.51 B | USA |
 |
Codexis
CDXS
|
4.35 | $ 1.29 | - | $ 94.7 M | USA |
 |
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | USA |
 |
AVROBIO
AVRO
|
0.594 | - | 1083.1 % | $ 745 M | USA |
 |
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | Germany |
 |
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
0.127 | $ 2.34 | 2.18 % | $ 14.7 M | USA |